Celgene to Acquire Delinia, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Celgene (CELG) PT Raised to $148 at Oppenheimer
January 26, 2017 3:32 PM ESTOppenheimer analyst Leah Rush Cann raised her price target on Celgene (NASDAQ: CELG) to $148.00 (from $141.00) while maintaining a Outperform rating.
Rush Cann commented, "Celgene reported a strong quarter and year-end that was in line with expectations. The outlook for Celgenes clinical... More



